Schubert & CO Alkermes Plc. Transaction History

Schubert & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$21.94 - $26.24 $285 - $341	-13 Reduced 68.42%	6 $0
Q3 2022 Oct 21, 2022	SELL	$22.0 - $31.87 $682 - $987	-31 Reduced 62.0%	19 $0
Q2 2022 Aug 01, 2022	BUY	$26.4 - $30.54 $844 - $977	32 Added 177.78%	50 $1,000
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $184 - $223	8 Added 80.0%	18 $0
Q4 2021 Jan 28, 2022	BUY	$21.47 - $32.08 $214 - $320	10 New	10 $0

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.9B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.